Prevent postnatal urinary incontinence by prenatal pelvic floor exercise? Rationale and protocol of the multicenter randomized study PreNatal Pelvic floor Prevention (3PN)

被引:9
作者
Fritel, X. [1 ]
Fauconnier, A.
de Tayrac, R. [2 ]
Amblard, J. [3 ]
Cotte, L.
Fernandez, H. [4 ]
机构
[1] CHR Reunion, Ctr Hosp Felix Guyon, Serv Gynecol Obstet, F-97405 St Denis, Reunion, France
[2] CHU Caremeau, Nimes, France
[3] CHU Hotel Dieu, Clermont Ferrand, France
[4] CHU Antoine Beclere, AP HP, Clamart, France
来源
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2008年 / 37卷 / 05期
关键词
Urinary incontinence; Pelvic floor exercise; Pregnancy; Randomized study;
D O I
10.1016/j.jgyn.2008.04.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction. - Female urinary incontinence (U I) is a frequent affection that generates handicap and expenses. There is a link between UI and pregnancy; onset of UI during pregnancy is a risk factor for permanent UI. Postnatal pelvic floor exercise has shown efficacy to improve postnatal UI. However, it remains uncertain if benefits last more than few months. Publication of our rationale for prenatal pelvic floor exercise is an opportunity to expose our pre-specified hypotheses and help health professionals' awareness. Objectives. -The purpose of PreNatal Pelvic floor Prevention (3PN) is to compare the effects of prenatal pelvic floor exercise versus sole written instructions on UI one year after delivery. Methods and population. - It is a multicenter, randomized, single blind study. Main inclusion criteria are first, single and non-complicated pregnancy over 18 years. Women randomized in pelvic floor exercise group will undergo eight sessions with a physiotherapist between six and eight months of pregnancy. Our principal criterion is UI score (international Consultation on Incontinence Questionnaire Short Form [ICIQ-SF]) one year after delivery. We plan to include 280 pregnant women in five centers over a 12-month screening period to show a one-point difference on UI score. Ethic and financing. -The study was approved by the IRB Comite de protection des personnes Sud-Ouest et Outre-Mer. It was registered by French Health Products Safety Agency (AFSSAPS) and ClinicalTrials.gov. It is supported by the French Ministry of Health through the 2007 Hospital Plan for Clinical Research (PHRC). (c) 2008 Elsevier Masson SAS.
引用
收藏
页码:441 / 448
页数:8
相关论文
共 48 条
[1]   Differences in management and results in term-delivery in nine European referral hospitals: descriptive study [J].
Alran, S ;
Sibony, O ;
Oury, JF ;
Luton, D ;
Blot, P .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 103 (01) :4-13
[2]   European psychometric validation of the CONTILIFE®:: A Quality of Life questionnaire for urinary incontinence [J].
Amarenco, G ;
Arnould, B ;
Carita, P ;
Haab, F ;
Labat, JJ ;
Richard, F .
EUROPEAN UROLOGY, 2003, 43 (04) :391-404
[3]  
*ANAES, 2002, REED CADR POSTP
[4]  
*ANAES, 2000, BIL TECHN REED PER S
[5]  
*ANAES, 2003, PRIS CHARG INC UR FE
[6]  
[Anonymous], EBMJ ENGLAND, DOI DOI 10.1136/BMJ.323.7313.593
[7]   ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence [J].
Avery, K ;
Donovan, J ;
Peters, TJ ;
Shaw, C ;
Gotoh, M ;
Abrams, P .
NEUROUROLOGY AND URODYNAMICS, 2004, 23 (04) :322-330
[8]  
Baessler K, 2004, NEUROUROL URODYNAM, V23, P398
[9]  
BARAU G, 1995, TROUBLES STAT PELVIE, P51
[10]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72